PMC5438008_01
Hepatitis B virus DNA and proteinuria during entecavir and tenofovir therapy: Entecavir was started in month 1 for HBV flare. Hepatitis B virus DNA (HBV-DNA) slowly reduced and was absent in month 16. Viral load rebound presented in month 39 so tenofovir was added to entecavir at this time point. In month 42, entecavir was stopped, and viral load continued to decrease gradually.
CNCS-4-018-01.jpg
PMC5438008_01_CNCS-4-018-01.jpg
Figure1
This time point was regarded as month 1 (Figure 1). 